|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-9
|
|
pubmed:abstractText |
To test the hypothesis that cardiopulmonary bypass used for repair of ventricular septal defects and atrioventricular septal defects would decrease availability of urea cycle intermediates including arginine and subsequent nitric oxide availability.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0022-3476
|
|
pubmed:author |
pubmed-author:BarrFrederick EFE,
pubmed-author:BeverleyHeidiH,
pubmed-author:CermakEmmaE,
pubmed-author:ChristianKarlaK,
pubmed-author:ChristmanBrianB,
pubmed-author:DrinkwaterDavisD,
pubmed-author:DyerKarrieK,
pubmed-author:MooreJason HJH,
pubmed-author:RaggioNoel TNT,
pubmed-author:SummarMarshallM,
pubmed-author:VanHookKristinK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
26-30
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12520250-Arginine,
pubmed-meshheading:12520250-Blood Urea Nitrogen,
pubmed-meshheading:12520250-Cardiopulmonary Bypass,
pubmed-meshheading:12520250-Citrulline,
pubmed-meshheading:12520250-Female,
pubmed-meshheading:12520250-Heart Defects, Congenital,
pubmed-meshheading:12520250-Humans,
pubmed-meshheading:12520250-Infant,
pubmed-meshheading:12520250-Infant, Newborn,
pubmed-meshheading:12520250-Male,
pubmed-meshheading:12520250-Nitric Oxide,
pubmed-meshheading:12520250-Ornithine,
pubmed-meshheading:12520250-Urea
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery.
|
|
pubmed:affiliation |
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
